image
Qualigen Therapeutics, Inc. QLGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.07
-7.67 %
$ 2.26 M
Market Cap
-0.17
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
-0.00%
Net Income Estimate
-0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Qualigen Therapeutics, Inc.
image
QLGN has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart QLGN

image
$10.0m$10.0m$9.0m$9.0m$8.0m$8.0m$7.0m$7.0m$6.0m$6.0m$5.0m$5.0m$4.0m$4.0m$3.0m$3.0m$2.0m$2.0m$1.0m$1.0m$0.0$0.0202020202021202120222022202320232024202420252025
EBIT FORECAST

EBIT Forecast Chart QLGN

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)202020202021202120222022202320232024202420252025
NET INCOME FORECAST

Net Income Chart QLGN

image
$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)202020202021202120222022202320232024202420252025